We explored the impact of PAHs exposure on lung function in the cohort design.
Certain and total PAHs lead to accelerated declines in FEV1/FVC and FEF25-75.
A 10-fold increase in urinary ΣOH-PAHs was associated with a 2.90% accelerated decline in FEV1/FVC.
A 10-fold increase in urinary ΣOH-PAHs was associated with a 292.91 mL accelerated decline in FEF25-75.